TMEM131L Antibody - BSA Free

Immunohistochemistry: TMEM131L Antibody - BSA Free [NBP2-30898] -

Decreased migration and invasive ability of U87 and U251 after interference with TMEM131L. (A,E,F) After interference with TMEM131L, the migratory and invasive capacity of U87 and U251 was decreased and cell numbers were quantified (n = 3); (B,G) After interfering with TMEM131L, the invasive ability of U87 and U251 was decreased and quantified for wounds (n = 3); (C,D,H) Prolonged cell cycle of U87 and U251 after interference with TMEM131L expression (n = 3). **p ≤ 0.01, ***p ≤ 0.001, and ****p ≤ 0.0001. Image collected and cropped by CiteAb from the following open publication (https://pubmed.ncbi.nlm.nih.gov/37090987), licensed under a CC-BY license. Not internally tested by Novus Biologicals.

Immunohistochemistry: TMEM131L Antibody - BSA Free [NBP2-30898] -

TMEM131L is elevated in glioma. (A) Expression of TMEM131L in low-grade gliomas (n = 8); (B) Expression of TMEM131L in high-grade gliomas (n = 8); (C,D) The mRNA and protein expression of TMEM131L in low-grade and high-grade gliomas was quantified (n = 6); (E) Detection and quantification of interference efficiency of si-TMEM131L-1 and si-TMEM131L-2 (n = 6). n.s > 0.05, ****p ≤ 0.0001. Image collected and cropped by CiteAb from the following open publication (https://pubmed.ncbi.nlm.nih.gov/37090987), licensed under a CC-BY license. Not internally tested by Novus Biologicals.